food%20allergy%20(pediatric)
FOOD ALLERGY (PEDIATRIC)
Food allergy is an adverse reaction due to a specific immune response occurring reproducibly upon exposure to certain foods. It occurs minutes to hours after food consumption.
Immunological mechanisms can be IgE mediated, non-IgE mediated or mixed IgE and non-IgE mediated.
It may be life-threatening and is the most common cause of anaphylaxis in children.
It should be differentiated from food intolerance in which adverse reactions from exposure to food arise from non-immunological mechanisms.

Patient Education

Patient/Caregiver Education 

  • Nutritional counseling & regular growth monitoring are recommended for all children w/ food allergy (FA)
  • Patient & caregivers should be educated on allergy to avoid inadvertent ingestion of food allergens
    • Learn to read food labels, to inquire at restaurants & take precautionary measures to prevent unintentional exposure to known food allergens
  • Medical information bracelet or necklace for the patient can provide important medical details when patient is found unconscious or cannot communicate due to the food-induced adverse reaction
  • Food allergy action plan should be developed, containing steps to take in case of a reaction
    • Include doses of medications & contact information for family members & health care providers
    • This plan should be thoroughly discussed w/ patients, family members & caregivers
    • Patients w/ history of food-induced anaphylaxis need to know how to use self-injectable Epinephrine
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
12 Jun 2019
In patients with type 2 diabetes, obesity may be protective against vision-threatening diabetic retinopathy, a recent Korea study has shown.
Yesterday
The aromatase inhibitor anastrozole shows promise in the treatment of children with congenital adrenal hyperplasia, reducing bone age advancement without adversely affecting bone mineral density and visceral adipose tissue, as shown in a recent study.
Roshini Claire Anthony, 6 days ago

Men with metastatic hormone-sensitive prostate cancer (mHSPC) who receive testosterone suppression therapy may have a better survival outcome with the addition of enzalutamide over other non-steroidal anti-androgen (NSAA) therapies, according to the phase III ENZAMET* trial.

6 days ago
The use of opioids may have limited long-term efficacy in the management of chronic noncancer pain, reports a new study.